首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1390864

製劑開發外包市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Formulation Development Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年全球製劑開發外包市場規模達226億美元。展望未來， IMARC Group預計到2028年市場規模將達到337億美元，2022-2028年複合年成長率（CAGR）為6.89%。

製劑開發是指確定藥品的專利性、生命週期和成功的過程。它還涉及預配製，包括分析測定開發和表徵、用於穩定或增強產品溶解度的賦形劑篩選以及劑型開發。由於時間壓力和缺乏內部資源，它經常被外包。配方開發外包還提供了許多好處，例如壓縮時間、獲取專業知識以及針對產品故障提供額外的保險。

製劑開發外包市場趨勢：

糖尿病、慢性阻塞性肺病 (COPD)、癌症、氣喘、關節炎和阿茲海默症等慢性病的盛行率不斷上升，刺激了對新藥發現和開發的需求。反過來，這也是導致製劑開發服務外包給世界各地的合約研究組織 (CRO) 的關鍵因素之一。除此之外，克服風險並節省藥物通過開發管道的時間和金錢的需求也在增加。因此，全球領先的製藥和生物技術公司正在藥物開發過程的早期階段與外包服務合作。再加上由於主要藥物專利到期時間的增加，對創新藥物的需求顯著增加，正在推動市場成長。此外，一些國家的企業和管理機構擴大醫療保健支出正在創造有利的市場前景。此外，冠狀病毒病（COVID-19）的爆發對臨床試驗的需求產生了積極影響，以找到針對傳染性感染的有效治療方法。這導致了對研發（R＆D）的廣泛投資，以開發治療方法，預計這將推動市場發展。

本報告回答的關鍵問題：

迄今為止，全球製劑開發外包市場的表現如何，未來幾年又將如何表現？
COVID-19 對全球製劑開發外包市場有何影響？
主要區域市場有哪些？
基於服務的市場區隔是什麼？
根據劑型，市場的詳細情形如何？
基於應用程式的市場區隔是什麼？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球製劑開發外包市場的架構如何？誰是主要參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Aizant Drug Research Solutions Private Limited
- Catalent Inc.
- Charles River Laboratories
- Dr. Reddy's Laboratories Ltd.
- Emergent BioSolutions Inc.
- Intertek Group plc
- Irisys LLC (Recro Pharma)
- Laboratory Corporation of America Holdings
- Lonza Group AG
- Piramal Pharma Solutions
- Quotient Sciences
- Syngene International Limited (Biocon Limited)
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112023A4747

Abstract

The global formulation development outsourcing market size reached US$ 22.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.89% during 2022-2028.

Formulation development refers to the process of determining patentability, lifecycle, and the success of the pharmaceutical product. It also involves pre-formulation, including analytical assay development and characterization, excipient screening to stabilize or enhance the solubility of the product and dosage form development. It is often outsourced due to time pressure and a lack of internal resources. Formulation development outsourcing also offers numerous benefits, such as compressing timelines, accessing expertise, and providing extra insurance against product failure.

Formulation Development Outsourcing Market Trends:

The growing prevalence of chronic diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), cancer, asthma, arthritis, and Alzheimer's disease, is catalyzing the demand for the discovery and development of new drugs. This, in turn, represents one of the key factors resulting in the formulation development services being outsourced to contract research organizations (CROs) around the world. Besides this, there is a rise in the need to overcome the risk and save time and money involved in passing the drug through the development pipeline. As a result, leading pharmaceutical and biotechnological companies worldwide are partnering with outsourcing services in the early phases of the drug development process. This, along with a significant increase in the need to innovate novel drugs on account of the rising patent expirations of major drugs, is contributing to market growth. Furthermore, expanding healthcare expenditure by business enterprises and governing agencies of several countries is creating a favorable market outlook. Moreover, the coronavirus disease (COVID-19) outbreak has positively influenced the need for clinical trials to find an effective treatment against the contagious infection. This has resulted in extensive investments in research and development (R&D) to develop therapeutics, which is projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global formulation development outsourcing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service, dosage form, application and end user.

Breakup by Service:

Pre-formulation Services

Discovery and Preclinical Services

Analytical Services

Formulation Optimization

Phase I

Phase II

Phase III

Phase IV

Breakup by Dosage Form:

Injectable

Oral

Topical

Others

Breakup by Application:

Oncology

Genetic Disorders

Neurology

Infectious Diseases

Respiratory

Cardiovascular

Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Government and Academic Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy's Laboratories Ltd., Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

How has the global formulation development outsourcing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global formulation development outsourcing market?
What are the key regional markets?
What is the breakup of the market based on the service?
What is the breakup of the market based on the dosage form?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global formulation development outsourcing market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Formulation Development Outsourcing Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Service

6.1 Pre-formulation Services
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Discovery and Preclinical Services
  - 6.1.2.2 Analytical Services
- 6.1.3 Market Forecast
6.2 Formulation Optimization
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Phase I
  - 6.2.2.2 Phase II
  - 6.2.2.3 Phase III
  - 6.2.2.4 Phase IV
- 6.2.3 Market Forecast

7 Market Breakup by Dosage Form

7.1 Injectable
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Oral
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Topical
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Application

8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Genetic Disorders
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Neurology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Infectious Diseases
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Respiratory
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Cardiovascular
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast

9 Market Breakup by End User

9.1 Pharmaceutical and Biopharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Government and Academic Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Aizant Drug Research Solutions Private Limited
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Catalent Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Charles River Laboratories
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Dr. Reddy's Laboratories Ltd.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Emergent BioSolutions Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Intertek Group plc
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Irisys LLC (Recro Pharma)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Laboratory Corporation of America Holdings
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Lonza Group AG
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Piramal Pharma Solutions
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
- 15.3.11 Quotient Sciences
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
- 15.3.12 Syngene International Limited (Biocon Limited)
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
- 15.3.13 Thermo Fisher Scientific Inc.
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio
  - 15.3.13.3 Financials
  - 15.3.13.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Formulation Development Outsourcing Market: Major Drivers and Challenges
Figure 2: Global: Formulation Development Outsourcing Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Formulation Development Outsourcing Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Formulation Development Outsourcing Market: Breakup by Service (in %), 2022
Figure 5: Global: Formulation Development Outsourcing Market: Breakup by Dosage Form (in %), 2022
Figure 6: Global: Formulation Development Outsourcing Market: Breakup by Application (in %), 2022
Figure 7: Global: Formulation Development Outsourcing Market: Breakup by End User (in %), 2022
Figure 8: Global: Formulation Development Outsourcing Market: Breakup by Region (in %), 2022
Figure 9: Global: Formulation Development Outsourcing (Pre-formulation Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Formulation Development Outsourcing (Pre-formulation Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Formulation Development Outsourcing (Formulation Optimization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Formulation Development Outsourcing (Formulation Optimization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Formulation Development Outsourcing (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Formulation Development Outsourcing (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Formulation Development Outsourcing (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Formulation Development Outsourcing (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Formulation Development Outsourcing (Topical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Formulation Development Outsourcing (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Formulation Development Outsourcing (Other Dosage Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Formulation Development Outsourcing (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Formulation Development Outsourcing (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Formulation Development Outsourcing (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Formulation Development Outsourcing (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Formulation Development Outsourcing (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Formulation Development Outsourcing (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Formulation Development Outsourcing (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Formulation Development Outsourcing (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Formulation Development Outsourcing (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Formulation Development Outsourcing (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Formulation Development Outsourcing (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Formulation Development Outsourcing (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Formulation Development Outsourcing (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Formulation Development Outsourcing (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Formulation Development Outsourcing (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: North America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: North America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: United States: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: United States: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Canada: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Canada: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Asia-Pacific: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Asia-Pacific: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: China: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: China: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Japan: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Japan: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: India: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: India: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: South Korea: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: South Korea: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Australia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Australia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Indonesia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Indonesia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Europe: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Europe: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Germany: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Germany: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: France: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: France: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: United Kingdom: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: United Kingdom: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Italy: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Italy: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Spain: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Spain: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Russia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Russia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Latin America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Latin America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Brazil: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Brazil: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Mexico: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Mexico: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Middle East and Africa: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Middle East and Africa: Formulation Development Outsourcing Market: Breakup by Country (in %), 2022
Figure 87: Middle East and Africa: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Global: Formulation Development Outsourcing Industry: SWOT Analysis
Figure 89: Global: Formulation Development Outsourcing Industry: Value Chain Analysis
Figure 90: Global: Formulation Development Outsourcing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Formulation Development Outsourcing Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Formulation Development Outsourcing Market Forecast: Breakup by Service (in Million US$), 2023-2028
Table 3: Global: Formulation Development Outsourcing Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
Table 4: Global: Formulation Development Outsourcing Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Formulation Development Outsourcing Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Formulation Development Outsourcing Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Formulation Development Outsourcing Market: Competitive Structure
Table 8: Global: Formulation Development Outsourcing Market: Key Players

02-2729-4219

+886-2-2729-4219